Risk factors for development of atypical femoral fractures in patients on long-term oral bisphosphonate therapy.
about
New insights into treatment of osteoporosis in postmenopausal womenDifference in Bone Mineral Density Change at the Lateral Femoral Cortices according to Administration of Different Bisphosphonate Agents.Bisphosphonates and atypical subtrochanteric fractures of the femur.Atypical femoral fractures in Italy: a retrospective analysis in a large urban emergency department during a 7-year period (2007-2013).Atypical Femoral Fracture in Rheumatoid Arthritis Patients Treated With Bisphosphonates: A Nested Case-Control Study.Factors associated with atypical femoral fracture.
P2860
Risk factors for development of atypical femoral fractures in patients on long-term oral bisphosphonate therapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Risk factors for development o ...... m oral bisphosphonate therapy.
@en
Risk factors for development o ...... m oral bisphosphonate therapy.
@nl
type
label
Risk factors for development o ...... m oral bisphosphonate therapy.
@en
Risk factors for development o ...... m oral bisphosphonate therapy.
@nl
prefLabel
Risk factors for development o ...... m oral bisphosphonate therapy.
@en
Risk factors for development o ...... m oral bisphosphonate therapy.
@nl
P2093
P50
P1433
P1476
Risk factors for development o ...... m oral bisphosphonate therapy.
@en
P2093
Leo Massari
Maria Rosaria Ambrosio
Paola Franceschetti
P304
P356
10.1016/J.BONE.2013.07.010
P577
2013-07-17T00:00:00Z